Medix Biochemica is hosting a webinar, “Soluble Biomarkers for Alzheimer's Disease.”
According to the company’s website, “Prof. Henrik Zetterberg will discuss the impact of AD, the pathology of the disease, and the current state of AD diagnosis. He will then provide an overview of the core soluble biomarkers for AD having the strongest supportive data to date and give a glimpse of interesting future biomarkers under study.
Next, R&D Manager Emilia Galli, will introduce Medix Biochemica's mAb launches and development pipeline related to AD markers.
After presentations, there's Q & A session. Webinar is hosted by Anthony Austin.”
The webinar will take place on Thursday, August 22, 2024, at 10:00 EDT.
